Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Burning Rock Biotech Limited - American Depositary Shares (NQ:BNR)

3.826 -0.204 (-5.05%)
Streaming Delayed Price Updated: 3:59 PM EDT, Jun 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Burning Rock Biotech Limited - American Depositary Shares

< Previous 1 2 Next >
Burning Rock Reports First Quarter 2025 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Announces Results of 2024 Annual General Meeting
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Reports Third Quarter 2024 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024
From Burning Rock Biotech Limited
Via GlobeNewswire
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Announces Changes to Management and Board of Directors
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Reports Second Quarter 2024 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Biotech Limited Announces Expected Delisting of American Depositary Shares
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
From Burning Rock Biotech Limited
Via GlobeNewswire
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Reports First Quarter 2024 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Publishes 2023 Annual Report on Form 20-F
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Announces ADS Ratio Change
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Announces Receipt of Notification from NASDAQ
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Announces Results of 2023 Annual General Meeting
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Reports Third Quarter 2023 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Reports Second Quarter 2023 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Announces Resignation and Appointment of Directors
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of Medicine
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Reports First Quarter 2023 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.